Biotricity Inc. (BTCY): Net Income
-$2.40M
Year ended 2026-03-31
-$2.69M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | -$2.40M | n/m | 2026-07-14, From 2025-04-01 |
| 2025-03-31 | -$8.42M | n/m | 2026-07-14, From 2024-04-01 |
| 2024-03-31 | -$14.09M | n/m | 2025-07-18, From 2023-04-01 |
| 2023-03-31 | -$18.66M | n/m | 2024-06-27, From 2022-04-01 |
| 2022-03-31 | -$29.13M | n/m | 2023-06-29, From 2021-04-01 |
| 2021-03-31 | -$15.49M | n/m | 2022-07-14, From 2020-04-01 |
| 2020-03-31 | -$11.07M | n/m | 2021-06-22, From 2019-04-01 |
| 2019-03-31 | -$8.59M | n/m | 2020-07-15, From 2018-04-01 |
| 2018-03-31 | -$8.62M | n/m | 2019-07-16, From 2017-04-01 |
| 2017-03-31 | -$7.81M | n/a | 2018-07-13, From 2016-04-01 |
| No annual figure between 2015-12-31 and 2017-03-31. | |||
| 2015-12-31 | -$5.19M | n/a | 2017-03-30, From 2015-01-01 |
| No annual figure between 2014-08-31 and 2015-12-31. | |||
| 2014-08-31 | -$91.1K | n/a | 2015-11-30, From 2013-09-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Biotricity Inc. (BTCY) | 2026-03-31 | -$2.40M | n/m |
| Profound Medical Corp. (PROF) | 2025-12-31 | -$42.57M | n/m |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | -$28.75M | n/m |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$21.17M | n/m |
| Nephros Inc (NEPH) | 2025-12-31 | $1.19M | n/m |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | -$3.17M | n/m |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | -$7.57M | n/m |
| DarioHealth Corp. (DRIO) | 2025-12-31 | -$41.71M | n/m |
| Nexgel, Inc. (NXGL) | 2025-12-31 | -$3.00M | n/m |
Compare BTCY, PROF, ALUR, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗